Navigation Links
Global $16.2 Billion Needle Free Diabetes Management Market 2017 - Device Type, Management Type Forecast to 2025 - Research and Markets
Date:2/16/2017

DUBLIN, Feb 16, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Needle Free Diabetes Management Market Analysis & Trends - Device Type, Management Type - Forecast to 2025" report to their offering.

The Global Needle Free Diabetes Management Market is poised to grow at a CAGR of around 17.6% over the next decade to reach approximately $16.2 billion by 2025.

Some of the prominent trends that the market is witnessing include increasing diabetic patients, increasing healthcare awareness, and recent technological developments of needle free drug delivery.

Based on device type the market is categorized into artificial pancreas devices & systems, diagnostic devices, and treatment devices. Further, diagnostic devices divided into flash glucose monitoring (FGM) system, and continuous glucose monitoring (CGM) system. Treatment devices divided into insulin patch & pump, insulin jet injector, insulin inhaler, and insulin pen.

By management type the market is classified into insulin patch & pumps, oral insulin, inhaled insulin, and other management types. Depending on the application the market is segmented by insulin delivery, and pain management.

This industry report analyzes the global markets for Needle Free Drug Delivery Devices across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Increasing Diabetic Patients
3.1.2 Increasing Healthcare Awareness
3.1.3 Recent Technological Developments of Needle Free Drug Delivery
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness

4 Needle Free Diabetes Management Market, By Device Type
4.1 Artificial Pancreas Devices & Systems
4.1.1 Artificial Pancreas Devices & Systems Market Forecast to 2025 (US$ MN)
4.2 Diagnostic Devices
4.2.1 Diagnostic Devices Market Forecast to 2025 (US$ MN)
4.2.1.1 Flash Glucose Monitoring (FGM) System
4.2.1.1.1 Flash Glucose Monitoring (FGM) System Market Forecast to 2025 (US$ MN)
4.2.1.2 Continuous Glucose Monitoring (CGM) System
4.2.1.2.1 Continuous Glucose Monitoring (CGM) System Market Forecast to 2025 (US$ MN)
4.3 Treatment Devices
4.3.1 Treatment Devices Market Forecast to 2025 (US$ MN)
4.3.1.1 Insulin Patch & Pump
4.3.1.1.1 Insulin Patch & Pump Market Forecast to 2025 (US$ MN)
4.3.1.2 Insulin Jet Injector
4.3.1.2.1 Insulin Jet Injector Market Forecast to 2025 (US$ MN)
4.3.1.3 Insulin Inhaler
4.3.1.3.1 Insulin Inhaler Market Forecast to 2025 (US$ MN)
4.3.1.4 Insulin Pen
4.3.1.4.1 Insulin Pen Market Forecast to 2025 (US$ MN)

5 Needle Free Diabetes Management Market, By Management Type
5.1 Insulin Patch & Pumps
5.1.1 Insulin Patch & Pumps Market Forecast to 2025 (US$ MN)
5.2 Oral Insulin
5.2.1 Oral Insulin Market Forecast to 2025 (US$ MN)
5.3 Inhaled Insulin
5.3.1 Inhaled Insulin Market Forecast to 2025 (US$ MN)
5.4 Other Management Types
5.4.1 Other Management Types Market Forecast to 2025 (US$ MN)

6 Needle Free Diabetes Management Market, By Application
6.1 Insulin Delivery
6.1.1 Insulin Delivery Market Forecast to 2025 (US$ MN)
6.2 Pain Management
6.2.1 Pain Management Market Forecast to 2025 (US$ MN)

7 Needle Free Diabetes Management Market, By Geography

8 Key Player Activities
8.1 Mergers & Acquisitions
8.2 Partnerships, Joint Venture's, Collaborations and Agreements
8.3 Product Launch & Expansions
8.4 Other Activities

9 Leading Companies
9.1 3M
9.2 Akra Dermojet
9.3 Antares Pharma Inc.
9.4 Bioject Medical Technologies, Inc.
9.5 Glide Pharmaceutical Technologies Ltd.
9.6 Injex Pharma AG
9.7 JDRF
9.8 Johnson & Johnson, Inc.
9.9 Medtronic, Inc.
9.10 Pancreum LLC
9.11 Pharmajet, Inc.
9.12 Tandem Diabetes Care, Inc.
9.13 Zogenix, Inc.

For more information about this report visit http://www.researchandmarkets.com/research/3g3kjb/global_needle

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-162-billion-needle-free-diabetes-management-market-2017---device-type-management-type-forecast-to-2025---research-and-markets-300408617.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview Reports by Global Industry Analysts
2. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
3. The Rockley Group and Content Rules Ink Deal to Extend Global Reach
4. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
5. Amgen To Present At The UBS Global Life Sciences Conference
6. HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
7. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City
8. PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems
9. Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
10. TRACE Releases 2012 Global Enforcement Report
11. Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2017)... 11, 2017  Thornhill Research Inc. ( ... an $8,049,024 USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by ... Commercial Corporation (CCC) ( Ottawa, Ontario, Canada ... administer general anesthesia to patients requiring emergency medical ... US Marine Corps have been a longtime partner ...
(Date:5/10/2017)... 10, 2017 Global Health Intelligence (GHI), ... America , published its 2017 ranking of the ... on extensive data analysis from GHI,s hospitals database for ... for the region. The GHI database covers 86% of the ... than 130 data points for each institution in key areas ...
(Date:5/10/2017)... May 10, 2017 Radiology has become the ... costs have also spiraled to the number one ranking ... radiology than ever before as the most complete and ... patient with lower back pain an MRI may confirm ... for pain, resulting in entirely different treatment protocols.  In ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... 26, 2017 , ... Boar’s Head Brand®, one of the ... Day entertaining that are sure to satisfy your guests’ flavor cravings, while adding ... cheeses featured in these refreshingly balanced recipes are packed with flavor, creating the ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... is focusing on the Peace Agreements being discussed by President Donald Trump and the ... race to try to speed up peace talks in the continuous battle between Israel ...
(Date:5/26/2017)... ... May 26, 2017 , ... “When the Stars Lead Home”: ... the creation of published author Laura Weigel Douglas, an avid reader who lives in ... house that sometimes feels like Green Hills Adventure Camp. She couldn’t be more grateful. ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... “Cactus Jack: ... had on so many others. “Cactus Jack: Against All Odds” is the creation ... Walter D. Hubbard is married to Jack Carlisle’s third child Jane. Walter. ...
(Date:5/24/2017)... ... 2017 , ... Dr. Alan I. Benvenisty, MD is dual board certified in ... known for his distinguished expertise and experience in the diagnosis and treatment of vascular ... treating renovascular disease and aortic aneurysm . He is known for his minimally ...
Breaking Medicine News(10 mins):